4.8 Article

Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Architecture and antigenicity of the Nipah virus attachment glycoprotein

Zhaoqian Wang et al.

Summary: A study found that a combination of two non-overlapping G-specific antibodies can synergistically neutralize Nipah and Hendra viruses and limit the emergence of escape mutants. Additionally, analysis of immune responses to NiV G in macaques vaccinated with a vaccine revealed that the receptor binding head domain is immunodominant. These findings provide therapeutic strategies for combating these deadly pathogens.

SCIENCE (2022)

Article Immunology

Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in Australia

Edward J. Annand et al.

Summary: Researchers have identified a novel Hendra virus variant in Australia that evades routine testing, yet is shown to have similarity to the prototypic virus. The current treatments and preventive measures are still effective against this variant. Upgraded surveillance and biosecurity practices are necessary to address the spreading risk of this variant.

EMERGING INFECTIOUS DISEASES (2022)

Article Virology

A new Hendra virus genotype found in Australian flying foxes

Jianning Wang et al.

Summary: A novel HeV genotype (HeV-g2) has been identified in two flying fox species submitted from three states in Australia, indicating the genetic diversity of HeV is broader than previously recognized.

VIROLOGY JOURNAL (2021)

Article Immunology

A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus

Thomas W. Geisbert et al.

Summary: A human subunit vaccine based on the attachment glycoprotein of Hendra virus was found to provide protection against both Nipah and Hendra viruses in a nonhuman primate model, starting as early as 7 days post immunization with a low dose. This vaccine could potentially serve as an efficient emergency tool to control the spread of Nipah disease during outbreaks.

NPJ VACCINES (2021)

Article Biochemistry & Molecular Biology

Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins

Ha V. Dang et al.

Summary: The research describes two cross-reactive F-specific antibodies, 1F5 and 12B2, that neutralize NiV and HeV through inhibition of membrane fusion by recognizing distinct prefusion-specific epitopes. The structural and functional characterization of these antibodies demonstrate the therapeutic potential of using antibody cocktails to protect against henipavirus infection. This study defines a roadmap for developing effective countermeasures against highly pathogenic viruses.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)

Article Multidisciplinary Sciences

Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies

Florian A. Lempp et al.

Summary: The study reveals that C-type lectin receptors and other factors can serve as attachment receptors for SARS-CoV-2 infection, enhancing ACE2-mediated infection and modulating the neutralizing activity of antibodies.

NATURE (2021)

Article Multidisciplinary Sciences

Broad sarbecovirus neutralization by a human monoclonal antibody

M. Alejandra Tortorici et al.

Summary: The emergence of SARS-CoV-2 variants and recurrent spillovers of coronaviruses into the human population emphasize the need for broadly neutralizing antibodies to prevent future zoonotic infections. The human monoclonal antibody S2X259 has shown promising results in neutralizing various forms of SARS-CoV-2 and potentially zoonotic sarbecoviruses by inhibiting the binding of ACE2 to the receptor-binding domain. This antibody targets a key antigenic site and may guide the design of vaccines effective against all sarbecoviruses.

NATURE (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

Tyler N. Starr et al.

Summary: An ideal therapeutic anti-SARS-CoV-2 antibody should have resistance to viral escape, activity against diverse sarbecoviruses, and provide high protection through viral neutralization and effector functions. Studies have found a trade-off between in vitro neutralization potency and breadth of sarbecovirus binding in SARS-CoV-2 antibodies targeting the RBD, but identified some antibodies with exceptional sarbecovirus breadth and resistance to SARS-CoV-2 escape.

NATURE (2021)

Article Cell Biology

Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein

Michael P. Doyle et al.

Summary: Human monoclonal antibodies targeting different antigenic sites were isolated from an individual previously exposed to Hendra virus vaccine, showing neutralization efficacy by blocking viral attachment to host cell receptors. These antibodies, with synergistic activity and protective effects in a stringent animal model of Nipah virus infection, may be suitable for cocktail therapeutic approach to achieve synergistic potency and reduce virus escape risk.

CELL REPORTS (2021)

Article Multidisciplinary Sciences

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

M. Alejandra Tortorici et al.

SCIENCE (2020)

Article Virology

Vaccines to Emerging Viruses: Nipah and Hendra

Moushimi Amaya et al.

ANNUAL REVIEW OF VIROLOGY, VOL 7, 2020 (2020)

Article Biochemistry & Molecular Biology

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Alexandra C. Walls et al.

Article Biochemistry & Molecular Biology

An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

Ha V. Dang et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)

Article Multidisciplinary Sciences

Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus

Eric D. Laing et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Multidisciplinary Sciences

A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex

Victoria A. Avanzato et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Biochemistry & Molecular Biology

MolProbity: More and better reference data for improved all-atom structure validation

Christopher J. Williams et al.

PROTEIN SCIENCE (2018)

Article Biochemistry & Molecular Biology

SWISS-MODEL: homology modelling of protein structures and complexes

Andrew Waterhouse et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Multidisciplinary Sciences

Monomeric ephrinB2 binding induces allosteric changes in Nipah virus G that precede its full activation

Joyce J. W. Wong et al.

NATURE COMMUNICATIONS (2017)

Article Immunology

Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo

Viktoriya Borisevich et al.

JOURNAL OF INFECTIOUS DISEASES (2016)

Article Multidisciplinary Sciences

Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form

Joyce J. W. Wong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Letter Biochemistry & Molecular Biology

Privateer: software for the conformational validation of carbohydrate structures

Jon Agirre et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)

Letter Biochemistry & Molecular Biology

Privateer: software for the conformational validation of carbohydrate structures

Jon Agirre et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)

Article Immunology

Hendra Virus Vaccine, a One Health Approach to Protecting Horse, Human, and Environmental Health

Deborah Middleton et al.

EMERGING INFECTIOUS DISEASES (2014)

Article Biochemical Research Methods

Towards automated crystallographic structure refinement with phenix.refine

Pavel V. Afonine et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2012)

Article Cell Biology

A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus Challenge

Katharine N. Bossart et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Article Microbiology

Cedar Virus: A Novel Henipavirus Isolated from Australian Bats

Glenn A. Marsh et al.

PLOS PATHOGENS (2012)

Article Cell Biology

A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge

Katharine N. Bossart et al.

SCIENCE TRANSLATIONAL MEDICINE (2011)

Article Biochemical Research Methods

Features and development of Coot

P. Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Biochemistry & Molecular Biology

Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2

Thomas A. Bowden et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)

Article Multidisciplinary Sciences

Host cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3

Kai Xu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Chemistry, Multidisciplinary

Phaser crystallographic software

Airlie J. McCoy et al.

JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)

Review Microbiology

Hendra and Nipah viruses: different and dangerous

BT Eaton et al.

NATURE REVIEWS MICROBIOLOGY (2006)

Article Multidisciplinary Sciences

Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus

MI Bonaparte et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus

OA Negrete et al.

NATURE (2005)